RaySearch Laboratories AB (publ) has announced that Iridium Network in Belgium has successfully treated its first patient using RaySearch’s oncology information system, RayCare®, alongside a Varian TrueBeam® linear accelerator.
Iridium Network, established in 2006, is the largest radiotherapy network in Belgium, offering specialized radiation oncology services across three hospital networks in the Antwerp region.
It is also recognized as a leading center of expertise on an international level. The network operates ten TrueBeam linear accelerators across four locations and treats over 6,000 patients annually with radiation therapy.
The collaboration between Iridium Network and RaySearch has been longstanding and significant. Iridium Network became a clinical partner to RaySearch in late 2015 with the acquisition of RayStation and has been instrumental in the development of RayCare.
In 2018, the network was the first globally to clinically implement RayCare, just two months after its release.
The interoperability certificate between RayCare 2024A and TrueBeam was issued in May 2024, covering all models in the TrueBeam family, including TrueBeam, TrueBeam STx, Edge, and VitalBeam.
Iridium Network has achieved a significant milestone by becoming the first hospital to use RayCare clinically with TrueBeam.
RayCare’s role in enhancing consistency and automation is crucial for maintaining patient safety, efficiency, and high-quality care. It significantly improves the ability to provide advanced radiation oncology services throughout Iridium Network.
The integration of RayCare with TrueBeam marks an important milestone in advancing patient-centered cancer care, reflecting a successful collaboration between industry and clinical experts.
